Federal Register / Vol. 75, No. 109 / Tuesday, June 8, 2010 / Notices 32505 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on January 

31, 2010, Meda Pharmaceuticals Inc., 

705 Eldorado Street, Decatur, Illinois 

62523, made application by letter to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Nabilone (7379), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance as a finished 

drug product in dosage form only for 

distribution to its customers. The 

company does not import the listed 

controlled substance in bulk active 

pharmaceutical ingredient (API) form. 

There are no domestic sources of 

Nabilone in finished drug product form 

available in the United States. The U.S. 

Food and Drug Administration has 

approved this product for medical use 

in the United States. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43, 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than July 8, 2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance listed in 

schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: May 28, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–13756 Filed 6–7–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 21, 2009, and 

published in the Federal Register on 

October 29, 2009 (74 FR 55858), 

Johnson Matthey, Inc., Pharmaceutical 

Materials, 2003 Nolte Drive, West 

Deptford, New Jersey 08066–1742, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Phenylacetone (8501) .................. II 

Coca Leaves (9040) ..................... II 

Thebaine (9333) ........................... II 

Opium, raw (9600) ....................... II 

Noroxymorphone (9668) .............. II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances as raw 

materials for use in the manufacture of 

bulk controlled substances for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Johnson Matthey, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Johnson 

Matthey, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: May 28, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–13737 Filed 6–7–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated January 27, 2010, and 

published in the Federal Register on 

February 5, 2010, (75 FR 6062), Wildlife 

Laboratories, 1401 Duff Drive, Suite 400, 

Fort Collins, Colorado 80524, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Etorphine Hydrochloride (9059), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance for sale to its 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Wildlife Laboratories to import the basic 

class of controlled substance is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Wildlife 

Laboratories to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 


emcdonald on DSK2BSOYB1PROD with NOTICES